Document Detail


Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances.
MedLine Citation:
PMID:  10694618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of the present study was to investigate whether the nitric oxide donor sodium nitroprusside can reduce the cardiac inflammatory response during coronary artery bypass grafting in patients with severely compromised left ventricular function. METHODS: Patients (n = 30) were assigned to receive placebo or sodium nitroprusside (0.5 microg. kg(-1). min(-1)) for the first 60 minutes of reperfusion. Interleukin 6, interleukin 8, and tumor necrosis factor alpha levels; platelet adhesion molecule CD41 and CD62 levels; and CD11b on leukocytes were determined in the radial artery and coronary sinus before cardiopulmonary bypass and during reperfusion (1, 5, 10, 35, and 75 minutes). RESULTS: At 1 minute of reperfusion, coronary venous levels of CD41-positive polymorphonuclear leukocytes were 8% lower than arterial levels in the placebo group and 18% higher in the sodium nitroprusside group (P =.021). At 5 minutes of reperfusion, the respective levels were 29% and 1% for interleukin 6 (P =.015), -5% and 20% for CD41-positive monocytes (P =.032), and -2% and 16% for CD11b-positive monocytes (P =.038). At 10 minutes of reperfusion, these levels were -14% and 21% for CD41-positive monocytes (P =.006). At 35 minutes of reperfusion, these levels were -13% and 7% for CD41-positive monocytes (P =.017), -41% and 23% for CD11b-positive monocytes (P =.001), and 7% and 25% for CD62-positive platelets (P =. 041). At 75 minutes of reperfusion, the levels were 15% and -7% for tumor necrosis factor alpha (P =.025) and -10% and 10% for CD62-positive platelets (P =.041). CONCLUSIONS: Transcardiac production of proinflammatory cytokines is reduced in patients undergoing coronary artery bypass grafting treated with the nitric oxide donor sodium nitroprusside. At the same time, less activated leukocytes and platelets are retained in the coronary circulation.
Authors:
P Massoudy; S Zahler; T Freyholdt; R Henze; A Barankay; B F Becker; S L Braun; H Meisner
Related Documents :
20200588 - Bilateral iliopsoas hematomas under sedation: a complication of postoperative therapy a...
19330248 - Effects of cardiopulmonary bypass on propofol pharmacokinetics and bispectral index dur...
11853218 - Combined innominate artery reconstruction and coronary artery bypass grafting.
7733718 - Cerebral microemboli during coronary artery bypass using different cardioplegia techniq...
12833488 - Inflammatory pulmonary nodules in kawasaki disease.
18412268 - Transcatheter occlusion of pulmonary arteriovenous malformations using the amplatzer va...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  119     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-04-13     Completed Date:  2000-04-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  566-74     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiovascular Surgery, University of Essen, Essen, Germany. parwis.massoudy@uni-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antigens, CD / blood*
Coronary Artery Bypass / adverse effects*
Double-Blind Method
Female
Humans
Interleukin-6 / blood*
Interleukin-8 / blood*
Male
Middle Aged
Nitroprusside / therapeutic use*
Postoperative Complications / blood*,  prevention & control*
Prospective Studies
Tumor Necrosis Factor-alpha / analysis*
Ventricular Dysfunction, Left / surgery*
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Interleukin-6; 0/Interleukin-8; 0/Tumor Necrosis Factor-alpha; 15078-28-1/Nitroprusside

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extended total arch replacement for acute type a aortic dissection: experience with seventy patients...
Next Document:  Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, ra...